This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mölling, P.
Right arrow Articles by Fredlund, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mölling, P.
Right arrow Articles by Fredlund, H.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 2001, p. 2695-2699, Vol. 39, No. 7
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.7.2695-2699.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Comparison of Serogroup W-135 Meningococci Isolated in Sweden during a 23-Year Period and Those Associated with a Recent Hajj Pilgrimage

Paula Mölling,1,* Anders Bäckman,1 Per Olcén,1 and Hans Fredlund1,2

National Reference Laboratory for Pathogenic Neisseria1 and Unit for Infectious Disease Control,2 Department of Clinical Microbiology & Immunology, Örebro Medical Centre Hospital, Örebro, Sweden

Received 5 December 2000/Returned for modification 26 February 2001/Accepted 7 April 2001

An outbreak of serogroup W-135 meningococcal disease was reported among pilgrims returning from the annual hajj (pilgrimage to Mecca) in mid-March 2000. Molecular characterization was used to investigate the similarity of the hajj-associated W-135 strains with those isolated in Sweden during a 23-year period (1978 to 2000). The same hajj-associated genosubtype, genosubtype P1.5,2,36b, has been documented in Sweden since 1979, while pulsed-field gel electrophoresis and the sulfadiazine resistance of the W-135 isolates indicated that the outbreak was probably due to a new clone of W-135 meningococci.


* Corresponding author. Mailing address: Department of Clinical Microbiology & Immunology, Örebro Medical Centre Hospital, SE-701 85 Örebro, Sweden. Phone: 46-19-602 15 20. Fax: 46-19-12 74 16. E-mail: paula.molling{at}orebroll.se.


Journal of Clinical Microbiology, July 2001, p. 2695-2699, Vol. 39, No. 7
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.7.2695-2699.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Giardina, P. C., Longworth, E., Evans-Johnson, R. E., Bessette, M. L., Zhang, H., Borrow, R., Madore, D., Fernsten, P. (2005). Analysis of Human Serum Immunoglobulin G against O-Acetyl-Positive and O-Acetyl-Negative Serogroup W135 Meningococcal Capsular Polysaccharide. CVI 12: 586-592 [Abstract] [Full Text]  
  • Taha, M.-K., Giorgini, D., Ducos-Galand, M., Alonso, J.-M. (2004). Continuing Diversification of Neisseria meningitidis W135 as a Primary Cause of Meningococcal Disease after Emergence of the Serogroup in 2000. J. Clin. Microbiol. 42: 4158-4163 [Abstract] [Full Text]  
  • Diggle, M.A., Clarke, S.C. (2003). Detection and genotyping of meningococci using a nested PCR approach. J Med Microbiol 52: 51-57 [Abstract] [Full Text]